You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

NIMOTOP Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Nimotop patents expire, and what generic alternatives are available?

Nimotop is a drug marketed by Bayer Pharms and is included in one NDA.

The generic ingredient in NIMOTOP is nimodipine. There are eight drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the nimodipine profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Nimotop

A generic version of NIMOTOP was approved as nimodipine by HERITAGE on May 2nd, 2007.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for NIMOTOP?
  • What are the global sales for NIMOTOP?
  • What is Average Wholesale Price for NIMOTOP?
Summary for NIMOTOP
Drug patent expirations by year for NIMOTOP
Recent Clinical Trials for NIMOTOP

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University Health Network, TorontoEarly Phase 1
Medical University of ViennaPhase 2
Rijnstate HospitalPhase 2

See all NIMOTOP clinical trials

US Patents and Regulatory Information for NIMOTOP

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Pharms NIMOTOP nimodipine CAPSULE;ORAL 018869-001 Dec 28, 1988 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for NIMOTOP

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bayer Pharms NIMOTOP nimodipine CAPSULE;ORAL 018869-001 Dec 28, 1988 ⤷  Sign Up ⤷  Sign Up
Bayer Pharms NIMOTOP nimodipine CAPSULE;ORAL 018869-001 Dec 28, 1988 ⤷  Sign Up ⤷  Sign Up
Bayer Pharms NIMOTOP nimodipine CAPSULE;ORAL 018869-001 Dec 28, 1988 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.